In this study, we demonstrated the utility and mechanism of JPH203, a newly developed LAT1-specific inhibitor, to inhibit tumor progression using a unique stroma-abundant allogeneic immunoreactive mouse colorectal tumor created by the orthotopic transplantation of a mouse-derived CRC cell line and MSCs in the mouse cecum. This evidence concerns the gene LAT and colorectal carcinoma.